 | • レポートコード：GIR-22F19242 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Compound Glycyrrhizin Injection Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の複合グリチルリチン注射の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 複合グリチルリチン注射市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・静脈注射、点滴 アプリケーション別セグメントは次のように区分されます。 ・病院調剤薬局、小売調剤薬局、その他 世界の複合グリチルリチン注射市場の主要な市場プレーヤーは以下のとおりです。 ・Shanxi PUDE Pharmaceutical、Xi'an Lijun Pharmaceutical、Beijing Kawin Technology Share-Holding、CSPC OUYI Pharmaceutical、North China Pharmaceutical、Cisen Pharmaceutical、Harbin Medisan Pharmaceutical、Anhui Hongye Pharmaceutical、Reyoung Pharmaceutical、Chengdu Easton Bio Pharmaceuticals 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、複合グリチルリチン注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な複合グリチルリチン注射メーカーの企業概要、2019年～2022年までの複合グリチルリチン注射の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な複合グリチルリチン注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別複合グリチルリチン注射の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの複合グリチルリチン注射のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での複合グリチルリチン注射市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および複合グリチルリチン注射の産業チェーンを掲載しています。 ・第13、14、15章では、複合グリチルリチン注射の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 複合グリチルリチン注射の概要 - タイプ別分析（2017年vs2021年vs2028年）：静脈注射、点滴 - アプリケーション別分析（2017年vs2021年vs2028年）：病院調剤薬局、小売調剤薬局、その他 - 世界の複合グリチルリチン注射市場規模・予測 - 世界の複合グリチルリチン注射生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Shanxi PUDE Pharmaceutical、Xi'an Lijun Pharmaceutical、Beijing Kawin Technology Share-Holding、CSPC OUYI Pharmaceutical、North China Pharmaceutical、Cisen Pharmaceutical、Harbin Medisan Pharmaceutical、Anhui Hongye Pharmaceutical、Reyoung Pharmaceutical、Chengdu Easton Bio Pharmaceuticals ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：静脈注射、点滴 ・アプリケーション別分析2017年-2028年：病院調剤薬局、小売調剤薬局、その他 ・複合グリチルリチン注射の北米市場分析 - 複合グリチルリチン注射の北米市場：タイプ別市場規模2017年-2028年 - 複合グリチルリチン注射の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・複合グリチルリチン注射のヨーロッパ市場分析 - ：複合グリチルリチン注射のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：複合グリチルリチン注射のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・複合グリチルリチン注射のアジア太平洋市場分析 - 複合グリチルリチン注射のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 複合グリチルリチン注射のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・複合グリチルリチン注射の南米市場分析 - 複合グリチルリチン注射の南米市場：タイプ別市場規模2017年-2028年 - 複合グリチルリチン注射の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・複合グリチルリチン注射の中東・アフリカ市場分析 - 複合グリチルリチン注射の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 複合グリチルリチン注射の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Compound Glycyrrhizin Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Compound Glycyrrhizin Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital Pharmacy accounting for % of the Compound Glycyrrhizin Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intravenous Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Compound Glycyrrhizin Injection include Shanxi PUDE Pharmaceutical, Xi’an Lijun Pharmaceutical, Beijing Kawin Technology Share-Holding, CSPC OUYI Pharmaceutical, and North China Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Compound Glycyrrhizin Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intravenous Injection
Intravenous Drip
Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
Others
The key market players for global Compound Glycyrrhizin Injection market are listed below:
Shanxi PUDE Pharmaceutical
Xi’an Lijun Pharmaceutical
Beijing Kawin Technology Share-Holding
CSPC OUYI Pharmaceutical
North China Pharmaceutical
Cisen Pharmaceutical
Harbin Medisan Pharmaceutical
Anhui Hongye Pharmaceutical
Reyoung Pharmaceutical
Chengdu Easton Bio Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Compound Glycyrrhizin Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Compound Glycyrrhizin Injection, with price, sales, revenue and global market share of Compound Glycyrrhizin Injection from 2019 to 2022.
Chapter 3, the Compound Glycyrrhizin Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Compound Glycyrrhizin Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Compound Glycyrrhizin Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Compound Glycyrrhizin Injection.
Chapter 13, 14, and 15, to describe Compound Glycyrrhizin Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Compound Glycyrrhizin Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Compound Glycyrrhizin Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intravenous Injection
1.2.3 Intravenous Drip
1.3 Market Analysis by Application
1.3.1 Overview: Global Compound Glycyrrhizin Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Compound Glycyrrhizin Injection Market Size & Forecast
1.4.1 Global Compound Glycyrrhizin Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Compound Glycyrrhizin Injection Sales in Volume (2017-2028)
1.4.3 Global Compound Glycyrrhizin Injection Price (2017-2028)
1.5 Global Compound Glycyrrhizin Injection Production Capacity Analysis
1.5.1 Global Compound Glycyrrhizin Injection Total Production Capacity (2017-2028)
1.5.2 Global Compound Glycyrrhizin Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Compound Glycyrrhizin Injection Market Drivers
1.6.2 Compound Glycyrrhizin Injection Market Restraints
1.6.3 Compound Glycyrrhizin Injection Trends Analysis
2 Manufacturers Profiles
2.1 Shanxi PUDE Pharmaceutical
2.1.1 Shanxi PUDE Pharmaceutical Details
2.1.2 Shanxi PUDE Pharmaceutical Major Business
2.1.3 Shanxi PUDE Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.1.4 Shanxi PUDE Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Xi’an Lijun Pharmaceutical
2.2.1 Xi’an Lijun Pharmaceutical Details
2.2.2 Xi’an Lijun Pharmaceutical Major Business
2.2.3 Xi’an Lijun Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.2.4 Xi’an Lijun Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Beijing Kawin Technology Share-Holding
2.3.1 Beijing Kawin Technology Share-Holding Details
2.3.2 Beijing Kawin Technology Share-Holding Major Business
2.3.3 Beijing Kawin Technology Share-Holding Compound Glycyrrhizin Injection Product and Services
2.3.4 Beijing Kawin Technology Share-Holding Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 CSPC OUYI Pharmaceutical
2.4.1 CSPC OUYI Pharmaceutical Details
2.4.2 CSPC OUYI Pharmaceutical Major Business
2.4.3 CSPC OUYI Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.4.4 CSPC OUYI Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 North China Pharmaceutical
2.5.1 North China Pharmaceutical Details
2.5.2 North China Pharmaceutical Major Business
2.5.3 North China Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.5.4 North China Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Cisen Pharmaceutical
2.6.1 Cisen Pharmaceutical Details
2.6.2 Cisen Pharmaceutical Major Business
2.6.3 Cisen Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.6.4 Cisen Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Harbin Medisan Pharmaceutical
2.7.1 Harbin Medisan Pharmaceutical Details
2.7.2 Harbin Medisan Pharmaceutical Major Business
2.7.3 Harbin Medisan Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.7.4 Harbin Medisan Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Anhui Hongye Pharmaceutical
2.8.1 Anhui Hongye Pharmaceutical Details
2.8.2 Anhui Hongye Pharmaceutical Major Business
2.8.3 Anhui Hongye Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.8.4 Anhui Hongye Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Reyoung Pharmaceutical
2.9.1 Reyoung Pharmaceutical Details
2.9.2 Reyoung Pharmaceutical Major Business
2.9.3 Reyoung Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.9.4 Reyoung Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Chengdu Easton Bio Pharmaceuticals
2.10.1 Chengdu Easton Bio Pharmaceuticals Details
2.10.2 Chengdu Easton Bio Pharmaceuticals Major Business
2.10.3 Chengdu Easton Bio Pharmaceuticals Compound Glycyrrhizin Injection Product and Services
2.10.4 Chengdu Easton Bio Pharmaceuticals Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Compound Glycyrrhizin Injection Breakdown Data by Manufacturer
3.1 Global Compound Glycyrrhizin Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Compound Glycyrrhizin Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Compound Glycyrrhizin Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Compound Glycyrrhizin Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Compound Glycyrrhizin Injection Manufacturer Market Share in 2021
3.5 Global Compound Glycyrrhizin Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Compound Glycyrrhizin Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Compound Glycyrrhizin Injection Market Size by Region
4.1.1 Global Compound Glycyrrhizin Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Compound Glycyrrhizin Injection Revenue by Region (2017-2028)
4.2 North America Compound Glycyrrhizin Injection Revenue (2017-2028)
4.3 Europe Compound Glycyrrhizin Injection Revenue (2017-2028)
4.4 Asia-Pacific Compound Glycyrrhizin Injection Revenue (2017-2028)
4.5 South America Compound Glycyrrhizin Injection Revenue (2017-2028)
4.6 Middle East and Africa Compound Glycyrrhizin Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Compound Glycyrrhizin Injection Sales in Volume by Type (2017-2028)
5.2 Global Compound Glycyrrhizin Injection Revenue by Type (2017-2028)
5.3 Global Compound Glycyrrhizin Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Compound Glycyrrhizin Injection Sales in Volume by Application (2017-2028)
6.2 Global Compound Glycyrrhizin Injection Revenue by Application (2017-2028)
6.3 Global Compound Glycyrrhizin Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Compound Glycyrrhizin Injection Sales by Type (2017-2028)
7.2 North America Compound Glycyrrhizin Injection Sales by Application (2017-2028)
7.3 North America Compound Glycyrrhizin Injection Market Size by Country
7.3.1 North America Compound Glycyrrhizin Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Compound Glycyrrhizin Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Compound Glycyrrhizin Injection Sales by Type (2017-2028)
8.2 Europe Compound Glycyrrhizin Injection Sales by Application (2017-2028)
8.3 Europe Compound Glycyrrhizin Injection Market Size by Country
8.3.1 Europe Compound Glycyrrhizin Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Compound Glycyrrhizin Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Compound Glycyrrhizin Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Compound Glycyrrhizin Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Compound Glycyrrhizin Injection Market Size by Region
9.3.1 Asia-Pacific Compound Glycyrrhizin Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Compound Glycyrrhizin Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Compound Glycyrrhizin Injection Sales by Type (2017-2028)
10.2 South America Compound Glycyrrhizin Injection Sales by Application (2017-2028)
10.3 South America Compound Glycyrrhizin Injection Market Size by Country
10.3.1 South America Compound Glycyrrhizin Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Compound Glycyrrhizin Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Compound Glycyrrhizin Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Compound Glycyrrhizin Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Compound Glycyrrhizin Injection Market Size by Country
11.3.1 Middle East & Africa Compound Glycyrrhizin Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Compound Glycyrrhizin Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Compound Glycyrrhizin Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Compound Glycyrrhizin Injection
12.3 Compound Glycyrrhizin Injection Production Process
12.4 Compound Glycyrrhizin Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Compound Glycyrrhizin Injection Typical Distributors
13.3 Compound Glycyrrhizin Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer